Surogran Tablets 50 Mg / 100 Mg 50 mg / 100 mg Tablet
PDF Leaflet Revision Date: 26 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Acute relief of migraine attacks with or without aura.
Dosage (summary)
Initial dose 50 mg, may increase to 100 mg; max 3 x 100 mg or 6 x 50 mg in 24 hours.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Hepatic impairment
- Elderly
- Children under 18
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Ergotamine
- MAOIs
- SSRIs
Contraindications
- Hypersensitivity to components
- Myocardial infarction
- Ischaemic heart disease
- Uncontrolled hypertension
- Severe hepatic impairment
Common side effects
- Chest pain
- Nausea
- Dizziness
- Fatigue
- Drowsiness
Counselling Points
- Use only for diagnosed migraine
- Avoid operating machinery if drowsy
- Monitor for cardiovascular symptoms
Serious warnings
- Risk of allergic reactions
- Transient chest symptoms may mimic angina
- Caution in cardiovascular disease
Important Disclaimer
The Surogran Tablets 50 Mg / 100 Mg 50 mg / 100 mg Tablet professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
